Free tool
FAERS Monitor: Emrosi
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 219015 or its brand name (Emrosi, Minocycline Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
18
Serious
4
22% of reports
Hospitalization
0
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dizziness4
- rash4
- back pain2
- gastrointestinal disorder2
- headache2
- product use in unapproved indication2
- pruritus2
- anaemia1
- arthralgia1
- burning sensation1
- condition aggravated1
- diarrhoea1
- disturbance in attention1
- dry skin1
- hand dermatitis1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2025 | 8 |
| 2026 | 10 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,141 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hand dermatitis | 1 | 1690.3 | 251.2 | 421 |
| gastrointestinal disorder | 2 | 26.1 | 7.1 | 27 |
| disturbance in attention | 1 | 21.7 | 3.2 | 4 |
| burning sensation | 1 | 16.7 | 2.5 | 3 |
| rashSignal | 4 | 10.7 | 4.5 | 27 |
| back pain | 2 | 10.1 | 2.7 | 9 |
| product use in unapproved indication | 2 | 9.4 | 2.6 | 8 |
| dizzinessSignal | 4 | 9.4 | 3.9 | 23 |
| dry skin | 1 | 8.8 | 1.3 | 1 |
| anaemia | 1 | 6.1 | 0.9 | 1 |
| pruritus | 2 | 6.1 | 1.6 | 4 |
| condition aggravated | 1 | 3.8 | 0.6 | 0 |
| headache | 2 | 3.7 | 1.0 | 2 |
| arthralgia | 1 | 2.8 | 0.4 | 0 |
| diarrhoea | 1 | 1.8 | 0.3 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.